News

01/08/2021

Dr. Ruth Karron Dispels Myths about COVID-19 Vaccines on The Brian Lehrer Show

Dr. Karron participated in the show’s third segment, called COVID-19 Vaccine 101, where she addressed topics like the nature of mRNA vaccines, vaccine hesitancy and myths including the unsubstantiated beliefs that COVID19 vaccines contain microchips and have the ability to change DNA.  

12/10/2020

What’s the Difference Between EUAs and Vaccine Licensure?

CIR Director Dr. Ruth Karron and faculty member Jessica Atwell answer Frequently Asked Questions regarding EUAs and COVID vaccine licensure.

11/18/2020

Johns Hopkins Center for Immunization Research to begin enrollment for CoVPN/AstraZeneca Phase 3 COVID-19 Vaccine Research Trial

The Center for Immunization Research at the Johns Hopkins Bloomberg School of Public Health is poised to begin enrolling study participants into a Phase 3 trial of the AstraZeneca COVID-19 vaccine AZD1222. The Center is one of approximately 80 sites in the United States that will evaluate this vaccine. About 30,000 participants will be enrolled in the study, which will evaluate the vaccine candidate for safety, efficacy, and immunogenicity against COVID-19. 

11/02/2020

CIR Participates in Licensed Flu Vaccine Clinic at Sacred Heart of Jesus Church

CIR faculty and staff in collaboration with Rite Aid and Notre Dame of Maryland Pharmacy gave back to the community at Friday’s Licensed Flu Vaccine Clinic at Sacred Heart of Jesus Church!

10/21/2020

The Vaccine News that Really Matters

The public now knows exactly how many infections these COVID-19 trials are planning for—and how many would trigger an interim analysis of early data. In an unprecedented but much-applauded move, the leading vaccine companies have released detailed trial protocols.

09/11/2020

Dr. Anna Durbin Discusses COVID-19 Vaccine Trials in Baltimore

Dr. Anna Durbin Discusses COVID-19 Vaccine Trials in Baltimore

08/13/2020

Johns Hopkins Center for Immunization Research Begins Enrollment for Pfizer/BioNTech Phase 2/3 COVID-19 Vaccine Research Trial

The Center for Immunization Research at the Johns Hopkins Bloomberg School of Public Health has begun enrolling study participants into a Phase 2/3 COVID-19 vaccine trial sponsored by BioNTech in collaboration with Pfizer.

HOW CLOSE ARE WE TO A SAFE, EFFECTIVE COVID-19 VACCINE?

How Close are we to a Safe, Effective COVID 19 Vaccine? The COVID-19 vaccine is on track to become the fastest-developed vaccine in history, but that doesn’t mean critical steps are being skipped. Ruth Karron, who leads the Center for Immunization Research at the Johns Hopkins Bloomberg School of Public Health, is one of the […]

Translate »